unconjugated hyperbilirubinemia (neonatal jaundice) in term neonates. unconjugated hyperbilirubinemia.
Conditions
Interventions
Control group only receive routine care and phototherapy ,It receive phototherapy plus UDCA 10 mg/kg/day orally in two divided doses.
No Intervention No treatment,Experimental Drug
Control,Interventional group
Sponsors
None listed
Eligibility
Sex/Gender
All
Age
37 Weeks to 41 Weeks
Inclusion criteria
Inclusion criteria: 1.Gestational age greater than 37 to 41, 2.birth weight of 2500 to 4000gram, 3.exclusive breast feed having total bilirubin of 12 to 20 mg/dl and direct bilirubin level less than 2mg/dl.
Exclusion criteria
Exclusion criteria: 1.Neonates were excluded if there was ABO and Rh incompatibility. 2.glucose 6 phosphate dehydrogenase deficiency (G6PDd), 3.history of any neurological or chronic diseases. 4.sepsis, 5.diseases leading to hyperbilirubinemia (e.g. A. Crigler- Najjar and Gilbert's syndromes, B.hypothyroidism, c.liver disease, 6.history of maternal diabetes, 7.parental dissatisfaction.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total serum bilirubin 72 hours It will be measured by Bilirubin Analyzer, an APEL BR-5200P Bilirubinometer by spectrophotometric method. | — |
Secondary
| Measure | Time frame |
|---|---|
| Material-specific wear and surface characteristics 1, 6, and 12 months Assessed using intraoral scanning (iTero) and clinical inspection | — |
Countries
Pakistan
Contacts
Public ContactSheikh Ali Ajmal
Sheikh zayed hospital Rahim yar khan
Outcome results
None listed